Badapple: Promiscuity patterns from noisy evidence

Journal of Cheminformatics

Volumn 8, Issue 1, 2016, Pages

  Yang, Jeremy J ^a   Ursu, Oleg ^a   Lipinski, Christopher A ^b   Sklar, Larry A ^a   Oprea, Tudor I ^a   Bologa, Cristian G ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b University of New Mexico School of Medicine ^*  (United States)

Author keywords

Compound promiscuity; Drug discovery informatics; High throughput screening (HTS); Molecular scaffolds; Statistical learning

Indexed keywords

EID: 85007557350     PISSN: None     EISSN: 17582946     Source Type: Journal    
DOI: 10.1186/s13321-016-0137-3     Document Type: Article

References (44)

1. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3-25
2. Rishton GM (1997) Reactive compounds and in vitro false positives in HTS. Drug Discov Today 2:382-384
3. Roche O et al (2002) Development of a virtual screening method for identification of "frequent hitters" in compound libraries. J Med Chem 45:137-142 Additional files Additional file 1. Supplementary figures. Additional file 2. Supplementary files.
4. McGovern SL, Helfand BT, Feng B, Shoichet BK (2003) A specific mechanism of nonspecific inhibition. J Med Chem 46:4265-4272
5. Seidler J, McGovern SL, Doman TN, Shoichet BK (2003) Identification and prediction of promiscuous aggregating inhibitors among known drugs. J Med Chem 46:4477-4486
6. Teague SJ, Davis AM, Leeson PD, Oprea TI (1999) The design of leadlike combinatorial libraries. Angew Chem Int Ed 38:3743-3748
7. Oprea TI, Davis AM, Teague SJ, Leeson PD (2001) Is there a difference between leads and drugs? A historical perspective. J Chem Inf Comput Sci 41:1308-1315
8. Ajay A, Walters WP, Murcko MA (1998) Can we learn to distinguish between "drug-like" and "nondrug-like" molecules? J Med Chem 41:3314-3324
9. Sadowski J, Kubinyi H (1998) A scoring scheme for discriminating between drugs and nondrugs. J Med Chem 41:3325-3329
10. Hann MM, Leach AR, Harper G (2001) Molecular complexity and its impact on the probability of finding leads for drug discovery. J Chem Inf Comput Sci 41:856-864
11. Hopkins AL, Groom CR, Alex A (2004) Ligand efficiency: a useful metric for lead selection. Drug Discov Today 9:430-431
12. Jahnke W, Erlanson D (2006) Fragment-based approaches in drug discovery. Wiley-VCH, Weinheim
13. Hajduk PJ, Greer J (2007) A decade of fragment-based drug design: strategic advances and lessons learned. Nat Rev Drug Discov 6:211-219
14. Olah MM, Bologa CG, Oprea TI (2004) Strategies for compound selection. Curr Drug Discov Technol 1:211-220
15. Hann M, Hudson B, Lewell X, Lifely R, Miller L, Ramsden N (1999) Strategic pooling of compounds for high-throughput screening. J Chem Inf Comput Sci 39:897-902
16. Huth JR, Mendoza R, Olejniczak ET, Johnson RW, Cothron DA, Liu Y, Lerner CG, Chen J, Hajduk PJ (2005) ALARM NMR: A rapid and robust experimental method to detect reactive false positives in biochemical screens. J Am Chem Soc 127:217-224
17. Yang Y, Chen H, Nilsson I, Muresan S, Engkvist O (2010) Investigation of the relationship between topology and selectivity for druglike molecules. J Med Chem 53:7709-7714
18. Hu Y, Bajorath J (2010) Polypharmacology directed compound data mining: identification of promiscuous chemotypes with different activity profiles and comparison to approved drugs. J Chem Inf Model 50:2112-2118
19. Baell JB, Holloway GA (2010) New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem 53:2719-2740
20. Austin CP, Brady LS, Insel TR, Collins FS (2004) NIH molecular libraries initiative. Science 306:1138-1139
21. Kaiser J (2008) Industrial-style screening meets academic biology. Science 321:764-766
22. NIH Molecular Libraries Program (2004-2013). https://commonfund.nih. gov/molecularlibraries. Accessed 15 Dec 2015
23. PubChem Compound. https://www.ncbi.nlm.nih.gov/pccompound?term=pccompound-pcassay-probe[filter]. Accessed 17 Nov 2015
24. Oprea TI, Bologa CG, Boyer S, Curpan RF, Glen RC, Hopkins AL, Lipinski CA, Marshall GR, Martin YC, Ostopovici-Halip L, Rishton G, Ursu O, Vaz RJ, Waller C, Waldmann H, Sklar LA (2009) A crowdsourcing evaluation of the NIH chemical probes. Nat Chem Biol 4:441-447
25. Arrowsmith CH et al (2015) The promise and peril of chemical probes. Nat Chem Biol 11:536-541
26. NIH Molecular Libraries Small Molecule Repository (2004-2013). http://mlsmr.evotec.com/MLSMR-HomePage/. Accessed 15 Dec 2015
27. MLSMR Excluded Functionality Filters (MLSMR Project Compound Identification) (2007). http://mlsmr.evotec.com/MLSMR-HomePage/identify. html. Accessed 15 Dec 2015
28. Edwards B, Gouveia K, Oprea T, Sklar L (2014) The University of New Mexico Center for Molecular Discovery. Comb Chem High Thr Screen 17:256-265
29. Tseng YJ, Martin E, Bologa CG, Shelat AA (2013) Cheminformatics aspects of high throughput screening: from robots to models: symposium summary. J Comput Aided Mol Des 27:443-453
30. BioAssay Ontology (BAO) (2012-2016) http://bioassayontology.org/. Accessed 15 Dec 2015
31. Vempati UD, Przydzial MJ, Chung C, Abeyruwan S, Mir A, Sakurai K, Visser U, Lemmon VP, Schürer SC (2012) Formalization, annotation and analysis of diverse drug and probe screening assay datasets using the BioAssay Ontology (BAO). PLoS One 7:e49198
32. BioAssay Research Database (BARD) (2012). http://bard.nih.gov. Accessed 8 Jun 2015
33. Wilkens SJ, Janes J, Su AI (2005) HierS: hierarchical scaffold clustering using topological chemical graphs. J Med Chem 48:3182-3193
34. Silver N (2012) The signal and the noise: why so many predictions fail-but some don't. Penguin Press, New York, p 321
35. IMDb Votes/Ratings Top Frequently Asked Questions. http://www.imdb.com/help/show-leaf?votestopfaq. Accessed 1 July 2014
36. de Souza A, Bittker JA, Lahr DA, Brudz S, Chatwin S, Oprea TI, Waller A, Yang JJ, Southall N, Guha R, Schurer SC, Vempati UD, Southern MR, Dawson ES, Clemons PA, Chung TDY (2014) An overview of the challenges in designing, integrating, and delivering BARD: a public chemical-biology resource and query portal for multiple organizations, locations, and disciplines. J Biomol Screen 19:614-627
37. Huth JR, Song D, Mendoza RR, Black-Schaefer CL, Mack JC, Dorwin SA, Ladror US, Severin JM, Walter KA, Bartley DM, Hajduk PJ (2007) Toxicological evaluation of thiol-reactive compounds identified using a la assay to detect reactive molecules by nuclear magnetic resonance. Chem Res Toxicol 20:1752-1759
38. Sutter P, Weis CD (1982) Ring opening reactions of 6H-anthra[1, 9-cd] isoxazol-6-ones and related compounds. J Heterocycl Chem 19:997-1011
39. Yoshimitsu O, Tetsushi W, Yoshiyasu T, Haruo N, Keiji W (2008) Genotoxic activation of 2-phenylbenzotriazole-type compounds by human cytochrome P4501A1 and N-acetyltransferase expressed in Salmonella typhimurium umu strains. Mutat Res 654:52-57
40. Bemis GW, Murcko MA (1996) The properties of known drugs. 1. Molecular frameworks. J Med Chem 39:2887-2893
41. JChem 5.8.3, ChemAxon (2012). http://www.chemaxon.com. Accessed 15 Dec 2015
42. HScaf repository (2012). http://github.com/jeremyjyang/unm-biocomphscaf. Accessed 15 Dec 2015
43. Badapple public web app (2013). http://pasilla.health.unm.edu/tomcat/badapple. Accessed 15 Dec 2015
44. OpenChord (2009). http://www.gnova.com. Accessed 15 Dec 2015